Dopamine D1 receptor, but not dopamine D2 receptor, is a critical regulator for acute cocaine-enhanced gene expression.
The aim of present study is to investigate the roles of dopamine receptor subfamilies and their subsequent molecular events in cocaine-enhanced gene expression in striatum. Acute cocaine-treated mice models were build to address this issue. Specific antagonists for dopamine D1 and D2 receptors (SCH 23390 and raclopride, respectively) and specific inhibitor for extracellular signal-regulated protein kinase 1/2 (ERK1/2) kinase were pretreated. Immunofluorescence was used to detect the expressions of c-Fos, phosphorylated cAMP response element binding (p-CREB) and phosphorylated Elk-1 (p-Elk-1) in striatum. Acute cocaine injection significantly enhanced expressions of c-Fos, p-CREB and p-Elk-1 in the striatum. Notably, these enhancements were totally blocked to normal level by SCH 23390 pre-treatment, while no changes occurred in the presence of raclopride. Moreover, we found that dopamine D1 receptor was involved in acute cocaine-induced activation of ERK1/2 in the striatum. Blockade of this dopamine D1 receptor-dependent ERK1/2 activation by SL 327 could reduce cocaine-enhanced expressions of c-Fos, p-CREB and p-Elk-1 in the striatum. These results suggest that dopamine D1 receptor, but not dopamine D2 receptor, plays a critical role in regulating acute cocaine-enhanced gene expression in the striatum, and ERK1/2 pathway may contribute to this regulation.